| Report ID | 276355 |
| Drug Identification Number | 02511061 |
| Brand name | ABRILADA |
| Common or Proper name | ABRILADA |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ADALIMUMAB |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 1x2 PRE-FILLED SYRINGE |
| ATC code | L04AB |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-03-30 |
| Actual start date | |
| Estimated end date | 2026-05-30 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-01-19 |
| Company comments | Please note that only one lot with an expiry date of 04/30/2026 remains available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-01-19 | French | Compare |
| v1 | 2026-01-19 | English | Compare |
Showing 1 to 2 of 2